IR@PKUHSC  > 北京大学临床肿瘤学院  > 胃肠肿瘤中心
学科主题临床医学
THE DUAL PI3K/mTOR INHIBITOR BEZ235 EXERTS PROMINENT ANTITUMOUR ACTIVITY IN HER2-POSITIVE GASTRIC CANCER AND HAS SYNERGY WITH TRASTUZUMAB
Zhu, Yan; Tian, Tian T.; Gao, Jing; Zou, Jian L.; Wang, Qi W.; Shen, Lin
刊名ANTICANCER RESEARCH
2015-07-01
35期:7页:4337-4338
收录类别SCI
文章类型Meeting Abstract
WOS标题词Science & Technology
类目[WOS]Oncology
研究领域[WOS]Oncology
语种英语
WOS记录号WOS:000357116400186
Citation statistics
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/50977
Collection北京大学临床肿瘤学院_胃肠肿瘤中心
作者单位Peking Univ Canc Hosp & Inst, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing, Peoples R China
Recommended Citation
GB/T 7714
Zhu, Yan,Tian, Tian T.,Gao, Jing,et al. THE DUAL PI3K/mTOR INHIBITOR BEZ235 EXERTS PROMINENT ANTITUMOUR ACTIVITY IN HER2-POSITIVE GASTRIC CANCER AND HAS SYNERGY WITH TRASTUZUMAB[J]. ANTICANCER RESEARCH,2015,35(7):4337-4338.
APA Zhu, Yan,Tian, Tian T.,Gao, Jing,Zou, Jian L.,Wang, Qi W.,&Shen, Lin.(2015).THE DUAL PI3K/mTOR INHIBITOR BEZ235 EXERTS PROMINENT ANTITUMOUR ACTIVITY IN HER2-POSITIVE GASTRIC CANCER AND HAS SYNERGY WITH TRASTUZUMAB.ANTICANCER RESEARCH,35(7),4337-4338.
MLA Zhu, Yan,et al."THE DUAL PI3K/mTOR INHIBITOR BEZ235 EXERTS PROMINENT ANTITUMOUR ACTIVITY IN HER2-POSITIVE GASTRIC CANCER AND HAS SYNERGY WITH TRASTUZUMAB".ANTICANCER RESEARCH 35.7(2015):4337-4338.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
谷歌学术
谷歌学术Similar articles in
[Zhu, Yan]'s Articles
[Tian, Tian T.]'s Articles
[Gao, Jing]'s Articles
百度学术
百度学术Similar articles in
[Zhu, Yan]'s Articles
[Tian, Tian T.]'s Articles
[Gao, Jing]'s Articles
必应学术
必应学术Similar articles in
[Zhu, Yan]'s Articles
[Tian, Tian T.]'s Articles
[Gao, Jing]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.